Literature DB >> 18600396

Changes in the expression of CD106, osteogenic genes, and transcription factors involved in the osteogenic differentiation of human bone marrow mesenchymal stem cells.

Feng Liu1, Yasuto Akiyama, Sachiko Tai, Kouji Maruyama, Yoshihiro Kawaguchi, Kouji Muramatsu, Ken Yamaguchi.   

Abstract

Mesenchymal stem cells (MSCs) are well known to possess multipotential differentiation and are becoming a good tool for clinical research. However, specific markers for their purification and the mechanism of their osteogenic differentiation remain to be elucidated. In the present study, we compared the expression of CD106, and osteogenic differentiation-related proteins and genes in human bone marrow (BM)-derived MSCs, before and after differentiation by FACS, histochemical staining, immunohistochemical staining, RT-PCR, and real-time PCR. It was found that MSCs were positive for CD13, CD29, CD44, CD73, CD90, CD105, and CD166, but negative for CD14, CD31, CD34, CD62E, CD45, and GlyA. Notably, CD106 was detected before osteogenic induction, but its expression was downregulated 10 fold after 2 weeks of osteogenic differentiation as determined by flow cytometry. The results of RT-PCR and real-time PCR revealed that the expression of CD106 mRNA in MSCs significantly decreased by 7.1-, 4.2-, and 5.1-fold, respectively after osteogenic, chondrogenic, and adipogenic differentiation. In contrast, other MSC-positive markers described above did not change significantly even after differentiation. Compared to levels in control cells, after 2 weeks of osteogenic differentiation, mRNA levels of alkaline phosphatase, bone sialoprotein, osteocalcin, and transcript factors RUNX2 and Osterix showed more than 2-fold, 5-fold, 1.5-fold, 2-fold, and 5-fold increase, respectively. Thus, we speculate that CD106 might be a useful surface marker for BMMSCs. Moreover, alkaline phosphatase, type I collagen, osteonectin, osteopontin, and biglycin were expressed in the early stages of osteogenic differentiation before bone sialoprotein and osteocalcin. The present study should help to provide a novel marker for isolating purified MSCs and characterizing osteogenic differentiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18600396     DOI: 10.1007/s00774-007-0842-0

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  29 in total

1.  Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells.

Authors:  Huilin Qi; Dean J Aguiar; Shelly M Williams; Alison La Pean; Wei Pan; Catherine M Verfaillie
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-11       Impact factor: 11.205

2.  STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: a comparative investigation in vitro.

Authors:  Karina Stewart; Peter Monk; Susan Walsh; Carolyn M Jefferiss; Julie Letchford; Jon N Beresford
Journal:  Cell Tissue Res       Date:  2003-07-22       Impact factor: 5.249

3.  Analysis of HLA-A24-restricted CMVpp65 peptide-specific CTL with HLA-A*2402-CMVpp65 tetramer.

Authors:  Yasuto Akiyama; Kiyotaka Kuzushima; Tatsuya Tsurumi; Ken Yamaguchi
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

Review 4.  Biological approaches to bone regeneration by gene therapy.

Authors:  R T Franceschi
Journal:  J Dent Res       Date:  2005-12       Impact factor: 6.116

5.  Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities.

Authors:  Federica Sabatini; Loredana Petecchia; Manuela Tavian; Vanina Jodon de Villeroché; Giovanni A Rossi; Danièle Brouty-Boyé
Journal:  Lab Invest       Date:  2005-08       Impact factor: 5.662

6.  Over-expression of ICAM-1, VCAM-1 and ELAM-1 might influence tumor progression in colorectal cancer.

Authors:  C A Maurer; H Friess; B Kretschmann; S Wildi; C Müller; H Graber; M Schilling; M W Büchler
Journal:  Int J Cancer       Date:  1998-02-20       Impact factor: 7.396

7.  Ectopic expression of vascular cell adhesion molecule-1 as a new mechanism for tumor immune evasion.

Authors:  Ken-Yu Lin; Dan Lu; Chien-Fu Hung; Shiwen Peng; Lanqing Huang; Chunfa Jie; Francisco Murillo; Jesse Rowley; Ya-Chea Tsai; Liangmei He; Dae-Jin Kim; Elizabeth Jaffee; Drew Pardoll; T-C Wu
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

8.  Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6.

Authors:  Michael S Friedman; Michael W Long; Kurt D Hankenson
Journal:  J Cell Biochem       Date:  2006-06-01       Impact factor: 4.429

9.  The promyelotic leukemia zinc finger promotes osteoblastic differentiation of human mesenchymal stem cells as an upstream regulator of CBFA1.

Authors:  Ryuji Ikeda; Kenichi Yoshida; So Tsukahara; Yoshiko Sakamoto; Hiroshi Tanaka; Ken-ichi Furukawa; Ituro Inoue
Journal:  J Biol Chem       Date:  2004-12-28       Impact factor: 5.157

10.  Cytotoxic T cell induction against human malignant melanoma cells using HLA-A24-restricted melanoma peptide cocktail.

Authors:  Yasuto Akiyama; Kouji Maruyama; Noriko Nara; Tohru Mochizuki; Akifumi Yamamoto; Naoya Yamazaki; Ichiro Kawashima; Ikuei Nukaya; Kazutoh Takesako; Ken Yamaguchi
Journal:  Anticancer Res       Date:  2004 Mar-Apr       Impact factor: 2.480

View more
  17 in total

1.  Depolarization alters phenotype, maintains plasticity of predifferentiated mesenchymal stem cells.

Authors:  Sarah Sundelacruz; Michael Levin; David L Kaplan
Journal:  Tissue Eng Part A       Date:  2013-06-05       Impact factor: 3.845

2.  Bone marrow osteoblastic niche: a new model to study physiological regulation of megakaryopoiesis.

Authors:  Isabella Pallotta; Michael Lovett; William Rice; David L Kaplan; Alessandra Balduini
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

3.  Characterization and evaluation of mesenchymal stem cells derived from human embryonic stem cells and bone marrow.

Authors:  Patrick T Brown; Matthew W Squire; Wan-Ju Li
Journal:  Cell Tissue Res       Date:  2014-06-14       Impact factor: 5.249

4.  Characterization and functionality of proliferative human Sertoli cells.

Authors:  Kitty Chui; Alpa Trivedi; C Yan Cheng; Diana B Cherbavaz; Paul F Dazin; Ai Lam Thu Huynh; James B Mitchell; Gabriel A Rabinovich; Linda J Noble-Haeusslein; Constance M John
Journal:  Cell Transplant       Date:  2010-11-05       Impact factor: 4.064

5.  Development of novel monoclonal antibodies that define differentiation stages of human stromal (mesenchymal) stem cells.

Authors:  Ditte C Andersen; Angela Kortesidis; Andrew C W Zannettino; Irina Kratchmarova; Li Chen; Ole N Jensen; Børge Teisner; Stan Gronthos; Charlotte H Jensen; Moustapha Kassem
Journal:  Mol Cells       Date:  2011-05-23       Impact factor: 5.034

6.  ALCAM: Basis Sequence: Mouse.

Authors:  Amanda G Hansen; Guido W Swart; Andries Zijlstra
Journal:  AFCS Nat Mol Pages       Date:  2011

7.  Temporal analysis of equine bone marrow aspirate during establishment of putative mesenchymal progenitor cell populations.

Authors:  Catherine H Radcliffe; M Julia B F Flaminio; Lisa A Fortier
Journal:  Stem Cells Dev       Date:  2010-02       Impact factor: 3.272

8.  Two-photon microscopy for non-invasive, quantitative monitoring of stem cell differentiation.

Authors:  William L Rice; David L Kaplan; Irene Georgakoudi
Journal:  PLoS One       Date:  2010-04-16       Impact factor: 3.240

9.  Isolation and characterization of ovine mesenchymal stem cells derived from peripheral blood.

Authors:  Jaber Lyahyai; Diego R Mediano; Beatriz Ranera; Arianne Sanz; Ana Rosa Remacha; Rosa Bolea; Pilar Zaragoza; Clementina Rodellar; Inmaculada Martín-Burriel
Journal:  BMC Vet Res       Date:  2012-09-22       Impact factor: 2.741

10.  Zoledrinic Acid Induces Steoblastic Differentiation of Mesenchymal Stem Cells without Change in Hypomethylation Status of OSTERIX Promoter.

Authors:  Majid Farshdousti Hagh; Mehrdad Noruzinia; Yousef Mortazavi; Masoud Soleimani; Saeid Kaviani; Maryam Mahmodinia Maymand
Journal:  Cell J       Date:  2012-08-31       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.